Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Xi Yang, Chenglong Li, MDand PhD, Rong Zhang, MDand PhD, Hong Zheng, MD PhD, Qing Wei, MD PhD, Chunsen Wang, MD, Jingying Dai, PhD, Xiaobing Huang, Ningning Tang

Blood (2019) 134 (Supplement_1): 2034.

https://doi.org/10.1182/blood-2019-124419

Published: 2019

Journal Articles

Novel Improvement of Haploidentical Hematopoietic Stem Cell Transplantation for Advanced Refractory/Relapsed Acute Leukemia

Fei Pan, Peihua Lu, Zhijie Wei, Rong Yang, Shuquan Ji, MD

Blood (2019) 134 (Supplement_1): 4593.

https://doi.org/10.1182/blood-2019-127820

Published: 2019

Journal Articles

Preemptive Administration of Ruxolitinib Rapidly Ameliorate Gvhd after Allo-Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study

Kangni Lin, Minmin Chen, Qian Li, Jinhua Ren, Haojie Zhu, Jingjing Xu, Rong Zheng, Zhizhe Chen, Jianda Hu, PhD, Ting Yang

Blood (2019) 134 (Supplement_1): 3293.

https://doi.org/10.1182/blood-2019-128003

Published: 2019

Journal Articles

Risk Factors and Different Therapeutic Patterns of Late-Onset Hemorrhagic Cystitis after Haploidentical Allogeneic Stem Cell Transplantation

Blood (2019) 134 (Supplement_1): 3261.

https://doi.org/10.1182/blood-2019-126230

Published: 2019

Journal Articles

Phase I Study of Yttrium-90 Labeled ANTI-CD25 (aTac) Monoclonal Antibody PLUS BEAM for Autologous Hematopoietic CELL Transplantation (AHCT) in Patients with Mature T-CELL NON-Hodgkin Lymphoma, the "a-TAC-BEAM Regimen"

Jasmine Zain, MD, Jennifer Simpson, Joycelynne Palmer, Jeffrey Wong, MD, Savita Dandapani, MD PhD, David Colcher, PhD, Nicole Karras, MD, Alex F. Herrera, MD, Amandeep Salhotra, MD, Auayporn P. Nademanee, MDBS, Ryotaro Nakamura, MD, Eileen P. Smith, MD, Ni-Chun Tsai, David Yamauchi, MD, Kofi Poku, PharmD, Van Biglang-awa, PharmD, John E. Shively

Blood (2018) 132 (Supplement 1): 611.

https://doi.org/10.1182/blood-2018-99-116907

Published: 2018

Journal Articles

Ruxolitinib Combined with Etanercept for Patients with Corticosteroid-Refractory Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation: A Multi-Center Prospective Study

Yanmin Zhao, MD, Jimin Shi, MD, Xiaoqing Li, Yi Luo, MD, Yamin Tan, MD, Xiaoyu Lai, PhD, Jian Yu, MD, Jianping Lan, PhD, Wanmao Ni, PhD, Lieguang Chen, MD, He Huang, MD PhD

Blood (2018) 132 (Supplement 1): 4561.

https://doi.org/10.1182/blood-2018-99-118649

Published: 2018

Journal Articles

Expandation of CD56-Bright NK Cell in Patients with Steroid-Refractory Graft-Versus-Host Disease Treated with Basiliximab and Etanercept

Lixia Sheng, MD, He Huang, MD PhD, Yamin Tan, Yi Luo, Yongxian Hu, Huarui Fu, Jimin Shi

Blood (2016) 128 (22): 5793.

https://doi.org/10.1182/blood.V128.22.5793.5793

Published: 2016

Journal Articles

Outcomes with Extracorporeal Photopheresis in the Management of Chronic Gvhd: A Multi-Centre Experience

David Routledge, MSc, BSc (Hons), FRCPath, MRCP, John Murray, BSc (hons), MSc, Fiona Dignan, MD, Amanda Calderwood, Adrian Bloor, Eleni Tholouli, Therese Callaghan, Muhammad Ameer Saif, MD FRCPath, MBBS, MRCP, Michael Dennis, FRCPath, James Cavet, FRCPath, Samar Kulkarni, MD MRCP, FRCPath

Blood (2016) 128 (22): 4595.

https://doi.org/10.1182/blood.V128.22.4595.4595

Published: 2016

Journal Articles

Reduced Non Relapse Mortality (NRM) and Survivable Acute Graft Versus Host Disease (GVHD) in the Current Era of Myeloablative Ex Vivo T-Cell Depleted (TCD) Transplantation

Natasha A Jain, MD, Prathima Anandi, MD, Upneet Chawla, BS, MD, Sawa Ito, MD PhD, Debbie Draper, RN, Eleftheria Koklanaris, RN, Sara Hauffe, RN, Jeanine Superata, RN, Robert Q. Le, MD PhD, David Stroncek, MD, Pawel Muranski, MD, Minoo Battiwalla, MD MS, John Barrett, MD

Blood (2016) 128 (22): 4596.

https://doi.org/10.1182/blood.V128.22.4596.4596

Published: 2016

Journal Articles

Excellent Therapeutic Results Achieved in Salvage Therapy for Steroid-Refractory Grades III-IV Acute Gvhd with Basiliximab and Etanercept: A Multicenter Prospective Study

Yamin Tan, Haowen Xiao, Jianping Lan, Yi Luo, Jimin Shi, Jingsong He, PhD, Xiaoyu Lai, Weiyan Zheng, Zhen Cai, He Huang, MD PhD

Blood (2015) 126 (23): 3130.

https://doi.org/10.1182/blood.V126.23.3130.3130

Published: 2015

Journal Articles

Haploidentical, G-CSF Primed, Unmanipulated Bone Marrow Transplantation with Anti-CD25 Monoclonal Antibody As Part of the Gvhd Prophylaxis for Patients with High-Risk Acute Myeloid Leukemia

Blood (2015) 126 (23): 4368.

https://doi.org/10.1182/blood.V126.23.4368.4368

Published: 2015

Journal Articles

Pre-Clinical Activity of Adct-301, a Novel Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies

Michael J Flynn, MBBCh, Patrick van Berkel, PhD, Francesca Zammarchi, PhD, Jean-Noel Levy, PhD, Arnaud Tiberghien, PhD, Luke A Masterson, PhD, François D'Hooge, PhD, Lauren Adams, David G Williams, PhD, Philip W Howard, PhD, John A Hartley, PhD

Blood (2014) 124 (21): 4491.

https://doi.org/10.1182/blood.V124.21.4491.4491

Published: 2014

Journal Articles

Changes in the T and B- Cell Subsets Following Treatment with a CD25-Antibody in Patients with Steroid Refractory GvHD

Geothy Chakupurakal, MBBS, MRCPath, PhD, Maria Garcia- Marquez, Alexander Shimabukuro- Vornhagen, MD, Hans Anton Schloesser, MD, Udo Holtick, MDPhD, Christoph Scheid, MD PhD, Michael von Bergwelt-Baildon, MD PhD

Blood (2014) 124 (21): 2497.

https://doi.org/10.1182/blood.V124.21.2497.2497

Published: 2014

Journal Articles

Survival of Patients with High Risk Hematological Malignancy after Allogeneic Transplant from HLA Identical Siblings Is Comparable to That of Patients Transplanted from Haploidentical, Unmanipulated Bone Marrow Donor: Results of a Matched-Pair Analysis from the Rome Transplant Network

Blood (2014) 124 (21): 1223.

https://doi.org/10.1182/blood.V124.21.1223.1223

Published: 2014

Journal Articles

Risk-Stratification Directed Prophylaxis with Additional Low-Dose of Methylprednisolone Can Reduce Acute Graft-Versus-Host Disease for Patients with Hematological Malignancies after Allogeneic SCT: A Randomized, Controlled, Clinical Trial

Ying-Jun Chang, Yu Wang, Lan-Ping Xu, Dai-Hong Liu, Kai-Yan Liu, Xiao-Hui Zhang, MD, PhD, Fei-Fei Tang, Huan Chen, Yu-Hong Chen, Xiao-Dong Mo, MD, Wei Han, MD, Chen-Hua Yan, Feng-Rong Wang, Yu-Qian Sun, Xiao Jun Huang

Blood (2014) 124 (21): 40.

https://doi.org/10.1182/blood.V124.21.40.40

Published: 2014

Journal Articles

Single Center Retrospective Comparison of Gvhd Preventive Regimens after Cy/Flu Minimal Intensity Allotransplantation

Praveen Ranganath, MBBS, Michael J. Robertson, MD, Rafat Abonour, MD, Jennifer E. Schwartz, MD FRCP(C), Sherif Farag, MBBS, PhD, Lisa l Wood, RN, Patrick Kiel, PharmD, Robert Nelson

Blood (2014) 124 (21): 5874.

https://doi.org/10.1182/blood.V124.21.5874.5874

Published: 2014

Journal Articles

Post-Transplantation Cyclophosphamide (PT-CY) After Myeloablative Conditioning Regimen (MAC) In Unmanipulated Haploidentical Bone Marrow Transplantation (hBMT) Is Highly Effective As Gvhd Prophylaxis and Disease Free Survival In Pediatric and Adult Patients With High Risk Leukemia

Maria Domenica Simone, MD, Anna Proia, MD, Alessandro Severino, MD, Alison Shardlow, MD, Novella Natale, MD, Francesca Spirito, MD, Mariagrazia Garzia, MD, Barbara Montante, MD, Anna Locasciulli, MD, Ignazio Majolino

Blood (2013) 122 (21): 4576.

https://doi.org/10.1182/blood.V122.21.4576.4576

Published: 2013

Journal Articles

Pilot Study Of Regulatory T Cell Depletion In The Setting Of Autologous Stem Cell Transplantation For Multiple Myeloma

Gottfried von Keudell, MD, PhD, Cara A Rosenbaum, MD, Todd M. Zimmerman, MD, Michael Bishop, MD, Koen van Besien, MD, Rebecca Malloy, RN, BSN, Amittha Wickrema, PhD, Andrzej Jakubowiak, MD, PhD, Justin Paul Kline, MD

Blood (2013) 122 (21): 4607.

https://doi.org/10.1182/blood.V122.21.4607.4607

Published: 2013

Journal Articles

Tocilizumab In The Treatment Of Steroid Refractory Graft Versus Host Disease: A Single Institutional Experience

Julianna V.F. Roddy, PharmD, BCOP, Bradley M. Haverkos, MD, MPH, Ali McBride, PharmD, Kathryn M Leininger, MD, Leslie A. Andritsos, MD, Steven M. Devine, MD, Yvonne A Efebera, MD

Blood (2013) 122 (21): 2067.

https://doi.org/10.1182/blood.V122.21.2067.2067

Published: 2013

Journal Articles

CMV Infection Alone Does Not Affect The Survival In Patients After Umbilical Cord Blood Transplantation: Can We Put Off The Time Of Preemptive Therapy?

Juan Tong, III, Zimin Sun, MD, Huilan Liu, MD, Kaiyang Ding, PhD, MD, Liangquan Geng, MD, Changcheng Zheng, MD, Baolin Tang, Xin Liu, MD

Blood (2013) 122 (21): 5458.

https://doi.org/10.1182/blood.V122.21.5458.5458

Published: 2013

NARROW

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Novel Improvement of Haploidentical Hematopoietic Stem Cell Transplantation for Advanced Refractory/Relapsed Acute Leukemia

Preemptive Administration of Ruxolitinib Rapidly Ameliorate Gvhd after Allo-Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Study

Risk Factors and Different Therapeutic Patterns of Late-Onset Hemorrhagic Cystitis after Haploidentical Allogeneic Stem Cell Transplantation

Phase I Study of Yttrium-90 Labeled ANTI-CD25 (aTac) Monoclonal Antibody PLUS BEAM for Autologous Hematopoietic CELL Transplantation (AHCT) in Patients with Mature T-CELL NON-Hodgkin Lymphoma, the "a-TAC-BEAM Regimen"

Ruxolitinib Combined with Etanercept for Patients with Corticosteroid-Refractory Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation: A Multi-Center Prospective Study

Expandation of CD56-Bright NK Cell in Patients with Steroid-Refractory Graft-Versus-Host Disease Treated with Basiliximab and Etanercept

Outcomes with Extracorporeal Photopheresis in the Management of Chronic Gvhd: A Multi-Centre Experience

Reduced Non Relapse Mortality (NRM) and Survivable Acute Graft Versus Host Disease (GVHD) in the Current Era of Myeloablative Ex Vivo T-Cell Depleted (TCD) Transplantation

Excellent Therapeutic Results Achieved in Salvage Therapy for Steroid-Refractory Grades III-IV Acute Gvhd with Basiliximab and Etanercept: A Multicenter Prospective Study

Haploidentical, G-CSF Primed, Unmanipulated Bone Marrow Transplantation with Anti-CD25 Monoclonal Antibody As Part of the Gvhd Prophylaxis for Patients with High-Risk Acute Myeloid Leukemia

Pre-Clinical Activity of Adct-301, a Novel Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies

Changes in the T and B- Cell Subsets Following Treatment with a CD25-Antibody in Patients with Steroid Refractory GvHD

Survival of Patients with High Risk Hematological Malignancy after Allogeneic Transplant from HLA Identical Siblings Is Comparable to That of Patients Transplanted from Haploidentical, Unmanipulated Bone Marrow Donor: Results of a Matched-Pair Analysis from the Rome Transplant Network

Risk-Stratification Directed Prophylaxis with Additional Low-Dose of Methylprednisolone Can Reduce Acute Graft-Versus-Host Disease for Patients with Hematological Malignancies after Allogeneic SCT: A Randomized, Controlled, Clinical Trial

Single Center Retrospective Comparison of Gvhd Preventive Regimens after Cy/Flu Minimal Intensity Allotransplantation

Post-Transplantation Cyclophosphamide (PT-CY) After Myeloablative Conditioning Regimen (MAC) In Unmanipulated Haploidentical Bone Marrow Transplantation (hBMT) Is Highly Effective As Gvhd Prophylaxis and Disease Free Survival In Pediatric and Adult Patients With High Risk Leukemia

Pilot Study Of Regulatory T Cell Depletion In The Setting Of Autologous Stem Cell Transplantation For Multiple Myeloma

Tocilizumab In The Treatment Of Steroid Refractory Graft Versus Host Disease: A Single Institutional Experience

CMV Infection Alone Does Not Affect The Survival In Patients After Umbilical Cord Blood Transplantation: Can We Put Off The Time Of Preemptive Therapy?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only